JERUSALEM, Nov. 08, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptides and small therapeutic proteins, today [...] Read more »
Ittihad announces Half Year 2024 Financial Results
ABU DHABI, United Arab Emirates, Sept. 04, 2024 (GLOBE NEWSWIRE) — Ittihad International Investment LLC ("Ittihad"; the "Company"), the leading industrial conglomerate in the UAE, today announces its Half Year 2024 [...] Read more »
Yili Reports FY2024 H1 Revenue of 59.9 Billion Yuan with 19% YoY Growth in Net Profit Attributable to the Parent Company
HOHHOT, China, Sept. 02, 2024 (GLOBE NEWSWIRE) — On August 29, Yili Group (600887.SS) released its FY2024 H1 report. During the reporting period, the company continued to solidify its industrial leadership with a total revenue of [...] Read more »
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates
JERUSALEM , Aug. 09, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, [...] Read more »